Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lactone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step chemical synthesis of pseudouridine using 2,3,5-tribenzyloxy-D-ribono-1,4-lactone. High yield, scalable process for mRNA therapeutics and reliable supply.
Novel photo-copper catalysis method enables efficient delta-lactone synthesis with high enantioselectivity. This technology offers reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing for global partners.
Novel one-pot two-step method using Iron(II) phthalocyanine for high-purity pharmaceutical intermediates with reduced costs and enhanced supply chain reliability.
Novel synthesis of anticancer annonaceolide analogs via simplified polyether chains. Cost-effective route for high-purity pharmaceutical intermediates.
Patent CN110437181B details a novel ester-based route for whiskey lactone, offering significant cost reduction in flavor manufacturing and enhanced supply chain reliability through mild hydrogenation.
Novel C14 hydroxylation method for triptolide derivatives. High yield Pd-catalyzed route ensures supply chain stability and cost efficiency for pharma intermediates.
Patent CN110240579B reveals a novel catalytic route for polysubstituted gamma-butyrolactones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN118359593A reveals a Ru/Cu bimetallic method for stereodivergent delta-lactone synthesis, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103415501A details stable iodoarene derivatives for high-ee spirolactone production. Enables cost reduction in pharma intermediate manufacturing with scalable catalytic routes.
Patent CN112209905B details a one-step iron-catalyzed synthesis for high-purity alpha-alkenyl lactones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111233795B reveals organic catalytic method. High yield and stereoselectivity ensure reliable supply chain for antitumor drug manufacturing.
Patent CN108084129B details a novel enantioselective Baeyer-Villiger oxidation for prostaglandin intermediates, offering high ee values and scalable manufacturing solutions.
Novel safe synthesis method for high purity intermediate. Reduces cost and risk. Reliable supply chain for pharmaceutical manufacturing.
Patent CN112680497A reveals enzymatic splitting for high-purity Corey lactone. Achieve significant cost reduction in API intermediate manufacturing and supply reliability.
Patent CN107163062A reveals mild sulphonyl lactone synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with high purity and scalability.
Novel one-pot method for beta-substituted azlactone derivatives eliminates phosphorus waste, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115181081A details a green asymmetric Baeyer-Villiger oxidation using an ionic cobalt complex. This method offers high yield, recyclability, and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113087689B reveals a metal-free synthesis for 5-amino-gamma-lactones. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.